Authors:
FAN X
GOMEZ L
NISTAL M
SIERRASESUMAGA L
CASTRESANA JS
Citation: X. Fan et al., DIFFERENTIAL POLYMERASE-CHAIN-REACTION - A TECHNICAL COMPARISON OF 3 METHODS FOR THE DETECTION OF CDK4 GENE AMPLIFICATION IN GLIOBLASTOMAS, International journal of oncology, 13(5), 1998, pp. 963-966
Authors:
MARTINEZ N
JIMENEZ E
CASTRESANA JS
SCHNEIDER J
Citation: N. Martinez et al., DETECTION OF P53 MUTATIONS IN GYNECOLOGIC TUMORS BY MEANS OF A SIMPLE, NONRADIOACTIVE MINIGEL METHOD OF PCR-SSCP ANALYSIS, Oncology Reports, 4(2), 1997, pp. 359-361
Authors:
GOMEZ L
RUBIO MP
MARTIN MT
VAZQUEZ JJ
IDOATE M
PASTORFIDE G
PESTANA A
SEIZINGER BR
BARNHILL RL
CASTRESANA JS
Citation: L. Gomez et al., CHROMOSOME-17 ALLELIC LOSS AND NF1-GRD MUTATIONS DO NOT PLAY A SIGNIFICANT ROLE AS MOLECULAR MECHANISMS LEADING TO MELANOMA TUMORIGENESIS, Journal of investigative dermatology, 106(3), 1996, pp. 432-436
Authors:
FLORES JF
WALKER GJ
GLENDENING JM
HALUSKA FG
CASTRESANA JS
RUBIO MP
PASTORFIDE GC
BOYER LA
KAO WH
BULYK ML
BARNHILL RL
HAYWARD NK
HOUSMAN DE
FOUNTAIN JW
Citation: Jf. Flores et al., LOSS OF THE P16(INK4A) AND P15(INK4B) GENES, AS WELL AS NEIGHBORING 9P21 MARKERS, IN SPORADIC MELANOMA, Cancer research, 56(21), 1996, pp. 5023-5032
Authors:
CASTRESANA JS
GOMEZ L
GAMALLO C
PALACIOS J
GARCIAMIGUEL P
QUEIZAN A
PESTANA A
Citation: Js. Castresana et al., THE STATUS OF NF1-GRD MUTATION AND P53 EXPRESSION IN NEUROBLASTOMA, International journal of oncology, 7(4), 1995, pp. 755-757
Authors:
GOMEZ L
BARRIOS C
KREICBERGS A
ZETTERBERG A
PESTANA A
CASTRESANA JS
Citation: L. Gomez et al., ABSENCE OF MUTATION AT THE GAP-RELATED DOMAIN OF THE NEUROFIBROMATOSIS TYPE-1 GENE IN SPORADIC NEUROFIBROSARCOMAS AND OTHER BONE AND SOFT-TISSUE SARCOMAS, Cancer genetics and cytogenetics, 81(2), 1995, pp. 173-174
Authors:
PIZARRO A
GAMALLO C
CASTRESANA JS
GOMEZ L
PALACIOS J
BENITO N
ESPADA J
FONSECA E
CONTRERAS F
Citation: A. Pizarro et al., P53 PROTEIN EXPRESSION IN VIRAL WARTS FROM PATIENTS WITH EPIDERMODYSPLASIA-VERRUCIFORMIS, British journal of dermatology, 132(4), 1995, pp. 513-519
Citation: J. Schneider et al., P-GLYCOPROTEIN, HER-2 NEU, AND MUTANT P53 EXPRESSION IN HUMAN GYNECOLOGIC TUMORS/, Journal of the National Cancer Institute, 86(11), 1994, pp. 850-855
Authors:
CASTRESANA JS
BELLO ML
REY JA
NEBREDA P
QUEIZAN A
GARCIAMIGUEL P
PESTANA A
Citation: Js. Castresana et al., NO TP53 MUTATIONS IN NEUROBLASTOMAS DETECTED BY PCR-SSCP ANALYSIS, Genes, chromosomes & cancer, 10(2), 1994, pp. 136-138
Citation: J. Schneider et al., IDENTIFICATION OF P53 MUTATIONS BY MEANS OF SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS IN GYNECOLOGICAL TUMORS - COMPARISON WITH THE RESULTS OF IMMUNOHISTOCHEMISTRY, European journal of cancer, 30A(4), 1994, pp. 504-508
Authors:
BARNHILL RL
CASTRESANA JS
RUBIO MP
MARTIN MT
IDOATE M
VAZQUEZ JJ
THOR AD
Citation: Rl. Barnhill et al., P53 EXPRESSION IN CUTANEOUS MALIGNANT-MELANOMA - AN IMMUNOHISTOCHEMICAL STUDY OF 87 CASES OF PRIMARY, RECURRENT, AND METASTATIC MELANOMA, Modern pathology, 7(5), 1994, pp. 533-535
Citation: C. Barrios et al., CLINICOPATHOLOGICAL CORRELATIONS AND SHORT-TERM PROGNOSIS IN MUSCULOSKELETAL SARCOMA WITH C-MYC ONCOGENE AMPLIFICATION, American journal of clinical oncology, 17(3), 1994, pp. 273-276
Authors:
CASTRESANA JS
BARRIOS C
GOMEZ L
KREICBERGS A
Citation: Js. Castresana et al., NO ASSOCIATION BETWEEN C-MYC AMPLIFICATION AND TP53 MUTATION IN SARCOMA TUMORIGENESIS, Cancer genetics and cytogenetics, 76(1), 1994, pp. 47-49
Authors:
BARRIOS C
CASTRESANA JS
FALKMER UG
ROSENDAHL I
KREICBERGS A
Citation: C. Barrios et al., C-MYC ONCOGENE AMPLIFICATION AND CYTOMETRIC DNA-PLOIDY PATTERN AS PROGNOSTIC FACTORS IN MUSCULOSKELETAL NEOPLASMS, International journal of cancer, 58(6), 1994, pp. 781-786
Authors:
CASTRESANA JS
RUBIO MP
KUNIMI K
BARRIOS C
KREICBERGS A
Citation: Js. Castresana et al., LACK OF MUTATION AT CODON 12 OF THE C-H-RAS ONCOGENE IN 51 HUMAN SARCOMAS ASSESSED BY PCR-RFLP, International journal of oncology, 2(5), 1993, pp. 823-825
Authors:
BARRIOS C
CASTRESANA JS
RUIZ J
KREICBERGS A
Citation: C. Barrios et al., AMPLIFICATION OF C-MYC ONCOGENE AND ABSENCE OF C-HA-RAS POINT MUTATION IN HUMAN BONE SARCOMA, Journal of orthopaedic research, 11(4), 1993, pp. 556-563
Authors:
CASTRESANA JS
BARRIOS C
RUIZ J
GOMEZ L
KREICBERGS A
Citation: Js. Castresana et al., SPORADIC AMPLIFICATION OF THE C-FMS PROTOONCOGENE IN HUMAN MUSCULOSKELETAL SARCOMAS, Anticancer research, 13(3), 1993, pp. 807-810
Authors:
CASTRESANA JS
RUBIO MP
VAZQUEZ JJ
IDOATE M
SOBER AJ
SEIZINGER BR
BARNHILL RL
Citation: Js. Castresana et al., LACK OF ALLELIC DELETION AND POINT MUTATION AS MECHANISMS OF P53 ACTIVATION IN HUMAN-MALIGNANT MELANOMA, International journal of cancer, 55(4), 1993, pp. 562-565
Authors:
FOUNTAIN JW
HALUSKA FG
GRAW SL
KAO WH
GITAI Z
BOYER LA
CASTRESANA JS
RUBIO MP
SEIZINGER B
BARNHILL R
WALKER GJ
HAYWARD NK
HOUSMAN DE
Citation: Jw. Fountain et al., MORE PRECISE DEFINITION OF THE 9P21 REGION LOST IN MELANOMA AND IDENTIFICATION OF A CANDIDATE GENE, American journal of human genetics, 53(3), 1993, pp. 170-170